Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)

Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)

Item
http://www.wikidata.org/entity/Q28296146
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphomaA single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.Clinical aspects of malt lymphomas.Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an updateBendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II studyChemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas.Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.
P2860

Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)

Item
http://www.wikidata.org/entity/Q28296146
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@ast
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@en
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@nl
type
label
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@ast
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@en
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@nl
prefLabel
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@ast
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@en
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Rituximab plus bendamustine is ...... ymphoid tissue (MALT lymphoma)
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698